Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1997
06/19/1997CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
06/19/1997CA2239873A1 Antifungal proteins
06/19/1997CA2239731A1 Antifungal proteins
06/19/1997CA2239293A1 Assay for and uses of peptide hormone receptor ligands
06/19/1997CA2236335A1 Agents for promoting bone formation
06/18/1997EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses
06/18/1997EP0779361A2 Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof
06/18/1997EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
06/18/1997EP0778948A1 Predictive test for hepatitis-b resistance
06/18/1997EP0778921A1 Pumping device
06/18/1997EP0778893A2 Bacterial production of hydrophobic polypeptides
06/18/1997EP0778892A1 Macrophage derived chemokine and chemokine analogs
06/18/1997EP0778891A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
06/18/1997EP0778889A2 Recombinant adenovirus comprising a chimeric penton base protein
06/18/1997EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
06/18/1997EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy
06/18/1997EP0778847A1 Immunostimulatory agents
06/18/1997EP0778785A2 Methods and apparatus for the delivery of solid drug compositions
06/18/1997EP0778779A2 Methods of inducing hair growth and coloration
06/18/1997EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity
06/18/1997EP0778767A2 Delivery of solid drug compositions
06/18/1997EP0778733A1 A basic protein composition for killing or inhibiting microbial cells
06/18/1997EP0580635B1 Modified plant viruses as vectors
06/18/1997EP0536363B1 Novel heparin derivatives and process for the preparation thereof
06/18/1997EP0521994B1 Pharmaceutical formulations
06/18/1997EP0516845B1 Novel megakaryocytic colony stimulating factor and process for its preparation
06/18/1997EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor
06/18/1997EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix
06/18/1997EP0447483B1 Dopamine receptors and genes
06/18/1997CN1152338A Streptogramines and method for preparing same by mutasynthesis
06/18/1997CN1152337A Superoxide dismutase-4
06/18/1997CN1152254A Therapeutic food composition and method to diminish blood sugar fluctuations
06/18/1997CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2
06/18/1997CN1151894A Pharmaceutical composition
06/18/1997CN1035193C Prep. of recomposing streptokinase
06/17/1997US5639947 Genetic engineering
06/17/1997US5639885 Sustained delivery of pharmacologically active peptides to brain
06/17/1997US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development
06/17/1997US5639872 Human VEGF-specific oligonucleotides
06/17/1997US5639869 Autoimmune diseases
06/17/1997US5639863 Isolated dna which codes for a variable region of the antibody which is active against glioma antigen
06/17/1997US5639858 Polypeptide
06/17/1997US5639856 Proteins that are modulators of nerve cell growth and regeneration
06/17/1997US5639855 Adrenomedullin
06/17/1997US5639852 Analogs of cyclosporin a
06/17/1997US5639796 Injectable medical composition and method of use
06/17/1997US5639783 Ketone derivatives
06/17/1997US5639781 Alcohol or aldehyde derivatives and their use
06/17/1997US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
06/17/1997US5639743 Administering synergistic amount of compound modulating endogenous prolactin levels and an androgen
06/17/1997US5639739 Useful for treating thrombosis in mammals by inhibiting trypsin-like serine protease enzymes
06/17/1997US5639736 Reducing neovascularization by administering through the eye
06/17/1997US5639732 Phosphorous-containing cysteine and serine protease inhibitors
06/17/1997US5639730 Heating in presence of a tenside
06/17/1997US5639729 Tripeptides useful in immune and CNS therapy
06/17/1997US5639728 Antineoplastic peptide
06/17/1997US5639727 Therapeutic uses of bactericidal/permeability increasing protein products
06/17/1997US5639726 Peptide mediated enhancement of thrombolysis methods and compositions
06/17/1997US5639725 Angiostatin protein
06/17/1997US5639724 Carrier medium comprising a transesterification product of a natural vegetable oil and glycerol: mixture of mon-, di- and triglycerides
06/17/1997US5639661 Genes and proteins for treating cystic fibrosis
06/17/1997US5639655 PML-RARA targeted ribozymes
06/17/1997US5639652 Nucleic acid encoding serotonin
06/17/1997US5639651 Gap-related gene, human IQGAP1
06/17/1997US5639647 2'-deoxy-2'alkylnucleotide containing nucleic acid
06/17/1997US5639640 Polypeptide
06/17/1997US5639639 Transforming a eukaryotic cell by inserting vector with dna coding for each of two subunits of hormone; culturing; expression
06/17/1997US5639638 DNA molecules encoding bone morpogenetic protein-11
06/17/1997US5639634 Useful for diagnosing tumors and targeting drug delivery
06/17/1997US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
06/17/1997US5639621 Immunoreactive with a polymorphic epithelial mucin antigen
06/17/1997US5639619 Screening assay for anti-HIV drugs using the Vpr gene
06/17/1997US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment
06/17/1997US5639598 Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
06/17/1997US5639592 Method for selecting a compound which disrupts function of activator protein 1 but does not promote transcriptional activation of steroid hormone responsive gene; for selecting compounds for treating cells undergoing uncontrolled growth
06/17/1997US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy
06/17/1997US5639481 Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine
06/17/1997US5639480 Sustained release formulations of water soluble peptides
06/17/1997US5639474 Cyclosporin soft capsule composition
06/17/1997US5639458 Class I MHC modulation of surface receptor activity
06/17/1997US5639455 Immunosuppressant
06/17/1997US5639453 Therapeutic uses of IL-3
06/17/1997US5639275 Capsule containing genetically engineered cells
06/16/1997CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses
06/16/1997CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses
06/16/1997CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses
06/16/1997CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof
06/16/1997CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
06/12/1997WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes
06/12/1997WO1997020939A1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
06/12/1997WO1997020938A2 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy
06/12/1997WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods
06/12/1997WO1997020930A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences
06/12/1997WO1997020929A1 Fibroblast growth factor fgf-10
06/12/1997WO1997020927A1 Compounds having lectin properties and biological uses thereof
06/12/1997WO1997020926A1 Il-13 receptor polypeptide
06/12/1997WO1997020925A1 Modified vegf antisense oligonucleotides for treatment of skin disorders
06/12/1997WO1997020924A1 A class of oligonucleotides, therapeutically useful as antitumoural agents
06/12/1997WO1997020919A1 Materials and methods for converting dna to co-dna
06/12/1997WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2
1 ... 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 ... 3163